IVIRMA, IVI Foundation, Avenida Fernando Abril Martorell, 106 - Torre A, Planta 1(a), 46026, Valencia, Spain; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale School of Medicine, 333 Cedar Street, New Haven CT 06510, USA; Universidad Rey Juan Carlos, Calle Tulipán s/n 28933 Móstoles, Madrid, Spain.
IVIRMA, IVI Foundation, Avenida Fernando Abril Martorell, 106 - Torre A, Planta 1(a), 46026, Valencia, Spain; Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Reprod Biomed Online. 2021 Apr;42(4):779-788. doi: 10.1016/j.rbmo.2021.01.004. Epub 2021 Jan 16.
Do donor spermatozoa improve IVF outcomes after first oocyte donation failure?
Retrospective, multicentre study including couples undergoing oocyte donation cycles using autologous or donor spermatozoa after a failed first attempt. Male partners were further characterized as normozoospermic or oligoasthenoteratospermic, i.e. fewer than 5 million motile progressive spermatozoa in the ejaculate. The main outcomes measured were live birth rate (LBR) per embryo transfer, LBR per number of embryos transferred, and cumulative LBR (CLBR) considering oocytes consumed in the previous donation cycles.
Analysis comprised 6065 cycles of oocyte donation failure; among these, subgroup analyses by sperm quality comprised 4113 cycles with severe male factor and 1150 cycles with suboptimal/normal spermatozoa. Sperm replacement in the first cycle after failure increased LBR per embryo transfer (OR 2.21, 95% CI 1.7-2.8, P < 0.001) and per number of embryos transferred (OR 2.46, 95% CI 1.9-3.1, P < 0.001) for normospermic and oligoasthenoteratospermic men. Replacement by the third cycle after failure was less beneficial (LBR per embryo transfer: OR 1.35, 95% CI 0.9-2.1, P = 0.16; LBR per embryos transferred: OR 1.33, 95% CI 0.9-2.0, P = 0.186). Kaplan-Meier curves of CLBR per oocyte fertilized with autologous or donor spermatozoa were statistically different (P < 0.001) and demonstrate how each additional oocyte may affect success based on sperm source (donor/autologous).
Donor spermatozoa improved outcomes when used after an initial failed oocyte donation cycle. The CLBR curves can be used to determine the cumulative chances of live birth using either autologous or donor spermatozoa, providing guidance on when to replace spermatozoa.
供精是否能改善首次卵母细胞捐赠失败后的 IVF 结局?
这是一项回顾性、多中心研究,纳入了首次尝试卵母细胞捐赠失败后接受自身或供精卵母细胞捐赠周期的夫妇。进一步根据精子质量将男性伴侣分为正常精子症或少弱精子症,即精液中向前运动的精子少于 500 万。主要结局测量指标为每个胚胎移植的活产率(LBR)、每个胚胎移植的 LBR 和考虑之前捐赠周期中消耗的卵母细胞的累积 LBR(CLBR)。
分析包括 6065 个卵母细胞捐赠失败周期;其中,根据精子质量进行亚组分析,包括 4113 个严重男性因素周期和 1150 个精子质量不佳/正常周期。在首次失败后周期中进行精子替代可提高每个胚胎移植的 LBR(OR 2.21,95%CI 1.7-2.8,P<0.001)和每个胚胎移植的 LBR(OR 2.46,95%CI 1.9-3.1,P<0.001),对于正常精子症和少弱精子症男性。在首次失败后第三个周期进行替代的获益较少(每个胚胎移植的 LBR:OR 1.35,95%CI 0.9-2.1,P=0.16;每个胚胎移植的 LBR:OR 1.33,95%CI 0.9-2.0,P=0.186)。使用自身或供精受精的每个卵母细胞的 CLBR 曲线具有统计学差异(P<0.001),并展示了根据精子来源(供精/自身),每个额外的卵母细胞如何影响成功的可能性。
供精可改善首次卵母细胞捐赠失败后的结局。CLBR 曲线可用于确定使用自身或供精的活产累积概率,为何时更换精子提供指导。